ITRM920222A0 - Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. - Google Patents

Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.

Info

Publication number
ITRM920222A0
ITRM920222A0 IT92RM222A ITRM920222A ITRM920222A0 IT RM920222 A0 ITRM920222 A0 IT RM920222A0 IT 92RM222 A IT92RM222 A IT 92RM222A IT RM920222 A ITRM920222 A IT RM920222A IT RM920222 A0 ITRM920222 A0 IT RM920222A0
Authority
IT
Italy
Prior art keywords
carnitine
acil
treatment
pharmaceutical compositions
compositions containing
Prior art date
Application number
IT92RM222A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM920222A0 publication Critical patent/ITRM920222A0/it
Priority to ITRM920222A priority Critical patent/IT1254314B/it
Priority to CA002092505A priority patent/CA2092505C/en
Priority to ES93830120T priority patent/ES2116429T3/es
Priority to JP06797193A priority patent/JP3616116B2/ja
Priority to EP93830120A priority patent/EP0566542B1/en
Priority to AT93830120T priority patent/ATE165241T1/de
Priority to DK93830120T priority patent/DK0566542T3/da
Priority to DE69318061T priority patent/DE69318061T2/de
Priority to KR1019930004877A priority patent/KR100244092B1/ko
Publication of ITRM920222A1 publication Critical patent/ITRM920222A1/it
Application granted granted Critical
Publication of IT1254314B publication Critical patent/IT1254314B/it
Priority to US08/612,671 priority patent/US5861434A/en
Priority to HK98109954A priority patent/HK1009325A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITRM920222A 1992-03-27 1992-03-27 Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. IT1254314B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITRM920222A IT1254314B (it) 1992-03-27 1992-03-27 Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
CA002092505A CA2092505C (en) 1992-03-27 1993-03-25 Pharmaceutical compositions containing l-carnitine or an acyl l-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders
DK93830120T DK0566542T3 (da) 1992-03-27 1993-03-26 Præparat omfattende L-carnitin eller acyl-L-carnitin i kombination med en ACE-hæmmer til behandling af kardiovaskulære fors
JP06797193A JP3616116B2 (ja) 1992-03-27 1993-03-26 心臓血管障害の処置のためのａｃｅ阻害剤を配合するｌ−カルニチンまたはアシル−ｌ−カルニチンを含む医薬組成物
EP93830120A EP0566542B1 (en) 1992-03-27 1993-03-26 Composition comprising L-carnitine or acyl-L-carnitine in combination with an ACE-inhibitor for the treatment of cardiovascular disorders
AT93830120T ATE165241T1 (de) 1992-03-27 1993-03-26 Zubereitung enthaltend l-carnitin oder acyl-l- carnitin in kombination mit einem ace-inhibitor zur behandlung von kardiovaskulären störungen
ES93830120T ES2116429T3 (es) 1992-03-27 1993-03-26 Composicion que contiene l-carnitina o acil-l-carnitina en combinacion con un inhibidor de ace para el tratamiento de trastornos cardiovasculares.
DE69318061T DE69318061T2 (de) 1992-03-27 1993-03-26 Zubereitung enthaltend L-Carnitin oder Acyl-L-Carnitin in Kombination mit einem ACE-Inhibitor zur Behandlung von kardiovaskulären Störungen
KR1019930004877A KR100244092B1 (ko) 1992-03-27 1993-03-27 L-카르니틴 또는 아실l-카르니틴과 ace-억제제를 함유한 심장혈관질환치료용 약제조성물과 그 치료방법
US08/612,671 US5861434A (en) 1992-03-27 1996-03-08 Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders
HK98109954A HK1009325A1 (en) 1992-03-27 1998-08-15 Composition comprising l-carnitine or acyl-l-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920222A IT1254314B (it) 1992-03-27 1992-03-27 Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.

Publications (3)

Publication Number Publication Date
ITRM920222A0 true ITRM920222A0 (it) 1992-03-27
ITRM920222A1 ITRM920222A1 (it) 1993-09-27
IT1254314B IT1254314B (it) 1995-09-14

Family

ID=11400880

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920222A IT1254314B (it) 1992-03-27 1992-03-27 Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.

Country Status (11)

Country Link
US (1) US5861434A (it)
EP (1) EP0566542B1 (it)
JP (1) JP3616116B2 (it)
KR (1) KR100244092B1 (it)
AT (1) ATE165241T1 (it)
CA (1) CA2092505C (it)
DE (1) DE69318061T2 (it)
DK (1) DK0566542T3 (it)
ES (1) ES2116429T3 (it)
HK (1) HK1009325A1 (it)
IT (1) IT1254314B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1284661B1 (it) * 1996-06-06 1998-05-21 Sigma Tau Ind Farmaceuti Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
LV12491B (lv) * 1998-10-29 2000-12-20 Ivars KALVIŅŠ Farmaceitiska kompozīcija
CA2350071A1 (en) * 1998-11-11 2000-05-18 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis
US20030206895A1 (en) * 1998-11-13 2003-11-06 Sigma-Tau Healthscience S.P.A. Antioxidant composition comprising propionyl L-carnitine and a flavonoid against throm-bosis and atherosclerosis
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
DE60031171T2 (de) * 2000-01-26 2007-08-23 Astellas Pharma Inc. Ace inhibitor-vasopressin antagonist kombinationen
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
SG193655A1 (en) * 2007-03-21 2013-10-30 Sigma Tau Ind Farmaceuti Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance
CN102640350B (zh) * 2009-02-18 2015-02-04 豪沃基金有限责任公司 超材料功率放大器系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
US5025001A (en) * 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
IT1235153B (it) * 1988-11-15 1992-06-22 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
IT1224795B (it) * 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
IT1240799B (it) * 1990-03-15 1993-12-17 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
IT1244636B (it) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT1248323B (it) * 1991-05-16 1995-01-05 Sigma Tau Ind Farmaceuti Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti
IT1245699B (it) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi

Also Published As

Publication number Publication date
JPH0616570A (ja) 1994-01-25
IT1254314B (it) 1995-09-14
DE69318061D1 (de) 1998-05-28
ITRM920222A1 (it) 1993-09-27
EP0566542A1 (en) 1993-10-20
EP0566542B1 (en) 1998-04-22
CA2092505A1 (en) 1993-09-28
DE69318061T2 (de) 1998-08-13
ES2116429T3 (es) 1998-07-16
JP3616116B2 (ja) 2005-02-02
DK0566542T3 (da) 1999-01-04
KR930019208A (ko) 1993-10-18
CA2092505C (en) 2004-06-01
US5861434A (en) 1999-01-19
ATE165241T1 (de) 1998-05-15
KR100244092B1 (ko) 2000-03-02
HK1009325A1 (en) 1999-05-28

Similar Documents

Publication Publication Date Title
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
BR1100824A (pt) Composto e composição farmacêutica
ITTO920063A0 (it) Soluzioni migliorate di zincato per il trattamento di alluminio e leghe di alluminio
ITRM940396A0 (it) Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
ITRM920222A0 (it) Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
ITRM940570A0 (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
NZ233122A (en) Synergistic pharmaceutical composition comprising ketanserine and an ace inhibitor
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO932850L (no) Fremgangsmaate for fremstilling av staal
ITMI940282A0 (it) Procedimento e dispositivo per la depurazione di sostanze sgrassanti
ITRM940571A0 (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT8521322A0 (it) Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche.
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
NO993784D0 (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
IT8223309A0 (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
EP0663209A3 (en) Medicines to inhibit the effects of amyloidogenic proteins.
IL108810A0 (en) Optical isomerization inhibitor and pharmaceutical compositions containing the same
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia